16-28842995-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_003321.5(TUFM):​c.1348A>G​(p.Lys450Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000805 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000085 ( 0 hom. )

Consequence

TUFM
NM_003321.5 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 3.15
Variant links:
Genes affected
TUFM (HGNC:12420): (Tu translation elongation factor, mitochondrial) This gene encodes a protein which participates in protein translation in mitochondria. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency resulting in lactic acidosis and fatal encephalopathy. A pseudogene has been identified on chromosome 17. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12547982).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUFMNM_003321.5 linkc.1348A>G p.Lys450Glu missense_variant Exon 10 of 10 ENST00000313511.8 NP_003312.3 P49411A0A384ME17
TUFMNM_001365360.2 linkc.1264A>G p.Lys422Glu missense_variant Exon 10 of 10 NP_001352289.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUFMENST00000313511.8 linkc.1348A>G p.Lys450Glu missense_variant Exon 10 of 10 1 NM_003321.5 ENSP00000322439.3 P49411
TUFMENST00000569217.1 linkn.657A>G non_coding_transcript_exon_variant Exon 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000517
AC:
13
AN:
251474
Hom.:
0
AF XY:
0.0000294
AC XY:
4
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000217
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000791
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000848
AC:
124
AN:
1461886
Hom.:
0
Cov.:
31
AF XY:
0.0000811
AC XY:
59
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000103
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000859
Hom.:
0
Bravo
AF:
0.0000680
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Feb 10, 2015
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Lys450Glu (AAG>GAG): c.1348 A>G in exon 10 of the TUFM gene (NM_003321.4) A variant of unknown significance has been identified in the TUFM gene. The K450E missense substitution has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. Mutations in the TUFM gene are associated with the autosomal recessive disorder combined oxidative phosphorylation deficiency 4. The amino acid substitution is non-conservative in that a positively charged Lysine residue is replaced by a negatively charged Glutamic Acid residue. This change occurs at a position in the TUFM gene that is highly conserved in mammals. Multiple in-silico analysis models predict that K450E is a benign sequence change. Therefore, based on the currently available information, it is unclear whether K450E is a disease-causing mutation or a rare benign variant. The variant is found in MITONUC-MITOP panel(s). -

Oct 24, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 215314). This variant has not been reported in the literature in individuals affected with TUFM-related conditions. This variant is present in population databases (rs199674838, gnomAD 0.02%). This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 450 of the TUFM protein (p.Lys450Glu). -

Inborn genetic diseases Uncertain:1
Jun 27, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1348A>G (p.K450E) alteration is located in exon 10 (coding exon 10) of the TUFM gene. This alteration results from a A to G substitution at nucleotide position 1348, causing the lysine (K) at amino acid position 450 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Combined oxidative phosphorylation defect type 4 Uncertain:1
Apr 11, 2018
Baylor Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
19
DANN
Uncertain
0.99
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.019
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.62
T
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.78
T
PrimateAI
Benign
0.42
T
PROVEAN
Benign
0.13
N
REVEL
Benign
0.18
Sift
Benign
0.25
T
Sift4G
Benign
0.49
T
Vest4
0.30
MVP
0.72
MPC
0.86
ClinPred
0.10
T
GERP RS
4.9
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199674838; hg19: chr16-28854316; API